Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Renal disease progression in autosomal dominant polycystic kidney disease.

Higashihara E, Horie S, Muto S, Mochizuki T, Nishio S, Nutahara K.

Clin Exp Nephrol. 2012 Aug;16(4):622-8. doi: 10.1007/s10157-012-0611-9. Epub 2012 Apr 21.

2.

Kidney volume and function in autosomal dominant polycystic kidney disease.

Higashihara E, Nutahara K, Okegawa T, Shishido T, Tanbo M, Kobayasi K, Nitadori T.

Clin Exp Nephrol. 2014 Feb;18(1):157-65. doi: 10.1007/s10157-013-0834-4. Epub 2013 Jul 18.

3.

Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.

Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP)..

Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20. Epub 2006 Nov 2.

4.

The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease.

Tokiwa S, Muto S, China T, Horie S.

Clin Exp Nephrol. 2011 Aug;15(4):539-45. doi: 10.1007/s10157-011-0428-y. Epub 2011 Mar 24.

PMID:
21431900
5.

Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.

Rule AD, Torres VE, Chapman AB, Grantham JJ, Guay-Woodford LM, Bae KT, Klahr S, Bennett WM, Meyers CM, Thompson PA, Miller JP; CRISP Consortium..

J Am Soc Nephrol. 2006 Mar;17(3):854-62. Epub 2006 Feb 1.

6.

Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan.

Yamashita T, Yoshida T, Ogawa T, Tsuchiya K, Nitta K.

Clin Exp Nephrol. 2011 Dec;15(6):831-40. doi: 10.1007/s10157-011-0501-6. Epub 2011 Jul 30.

PMID:
21800234
7.

Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney disease.

Haseebuddin M, Tanagho YS, Millar M, Roytman T, Chen C, Clayman RV, Miller B, Desai A, Benway B, Bhayani S, Figenshau RS.

J Urol. 2012 Oct;188(4):1239-44. doi: 10.1016/j.juro.2012.06.026. Epub 2012 Aug 16.

PMID:
22902029
8.

Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease.

Panizo N, Goicoechea M, García de Vinuesa S, Arroyo D, Yuste C, Rincón A, Verdalles U, Ruiz-Caro C, Quiroga B, Luño J.

Nefrologia. 2012;32(2):197-205. doi: 10.3265/Nefrologia.pre2011.Dec.11177. Epub 2012 Jan 27. English, Spanish.

9.

Natural history of CKD stage 4 and 5 patients following referral to renal management clinic.

Zhang AH, Tam P, LeBlanc D, Zhong H, Chan CT, Bargman JM, Oreopoulos DG.

Int Urol Nephrol. 2009 Dec;41(4):977-82. doi: 10.1007/s11255-009-9604-3. Epub 2009 Jul 4.

PMID:
19578968
10.

Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease.

Chen D, Ma Y, Wang X, Yu S, Li L, Dai B, Mao Z, Sun L, Xu C, Rong S, Tang M, Zhao H, Liu H, Serra AL, Graf N, Liu S, Wüthrich RP, Mei C.

PLoS One. 2014 Mar 20;9(3):e92232. doi: 10.1371/journal.pone.0092232. eCollection 2014.

11.

Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.

Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME.

J Am Soc Nephrol. 1995 Jun;5(12):2037-47. Erratum in: J Am Soc Nephrol 1995 Oct;6(4):1318.

12.

Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease.

Han M, Park HC, Kim H, Jo HA, Huh H, Jang JY, Kang AY, Kim SH, Cheong HI, Kang DH, Yang J, Oh KH, Hwang YH, Ahn C.

BMC Nephrol. 2014 Apr 16;15:63. doi: 10.1186/1471-2369-15-63.

13.

Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.

Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grünfeld JP, Jungers P.

J Am Soc Nephrol. 1995 Dec;6(6):1634-42.

14.

Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.

Higashihara E, Torres VE, Chapman AB, Grantham JJ, Bae K, Watnick TJ, Horie S, Nutahara K, Ouyang J, Krasa HB, Czerwiec FS; TEMPOFormula and 156-05-002 Study Investigators..

Clin J Am Soc Nephrol. 2011 Oct;6(10):2499-507. doi: 10.2215/CJN.03530411. Epub 2011 Sep 8.

15.

Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.

Othman M, Kawar B, El Nahas AM.

Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10.

PMID:
19590231
16.

Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.

Heffernan KS, Kuvin JT, Sarnak MJ, Perrone RD, Miskulin DC, Rudym D, Chandra P, Karas RH, Menon V.

Nephrol Dial Transplant. 2011 Aug;26(8):2515-21. doi: 10.1093/ndt/gfq806. Epub 2011 Feb 3.

17.

Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.

Helal I, McFann K, Reed B, Yan XD, Schrier RW, Fick-Brosnahan GM.

Nephrol Dial Transplant. 2013 Feb;28(2):380-5. doi: 10.1093/ndt/gfs417. Epub 2012 Dec 4.

18.

The natural history of autosomal dominant polycystic kidney disease: 30-year experience from a single centre.

Thong KM, Ong AC.

QJM. 2013 Jul;106(7):639-46. doi: 10.1093/qjmed/hct082. Epub 2013 Apr 15.

PMID:
23587574
19.

Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.

Miskulin DC, Abebe KZ, Chapman AB, Perrone RD, Steinman TI, Torres VE, Bae KT, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Moore CG, Flessner MF, Schrier RW; HALT-PKD Study..

Am J Kidney Dis. 2014 Feb;63(2):214-26. doi: 10.1053/j.ajkd.2013.08.017. Epub 2013 Nov 1.

20.

Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?

Higashihara E, Nutahara K, Tanbo M, Hara H, Miyazaki I, Kobayashi K, Nitatori T.

Nephrol Dial Transplant. 2014 Sep;29(9):1710-9. doi: 10.1093/ndt/gfu093. Epub 2014 Apr 15.

Supplemental Content

Support Center